{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:06:46Z","timestamp":1790928406583,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006396","name":"Qazvin University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ibneur.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:56:47Z","timestamp":1736427407000},"page":"191-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge"],"prefix":"10.1016","volume":"18","author":[{"given":"Shahram","family":"Darabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enam Alhagh Charkhat","family":"Gorgich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-5631","authenticated-orcid":false,"given":"Auob","family":"Rustamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","article-title":"The changing prevalence and incidence of dementia over time\u2014current evidence","volume":"13","author":"Wu","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib3","first-page":"1","article-title":"Alzheimer\u2019s Disease: epidemiology and Clinical Progression","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2022-100751","article-title":"The China Alzheimer Report 2022","volume":"35","author":"Ren","year":"2022","journal-title":"Gen. Psychiatry"},{"key":"10.1016\/j.ibneur.2025.01.004_bib5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3389\/fphar.2019.01355","article-title":"Therapeutic effects of natural drugs on Alzheimer\u2019s disease","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3934\/Neuroscience.2021005","article-title":"The biological pathways of Alzheimer disease: a review","volume":"8","author":"Calabr\u00f2","year":"2021","journal-title":"AIMS Neurosci."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1582-4934.2008.00313.x","article-title":"Biomarkers for early diagnosis of Alzheimer disease:\u2018ALZheimer ASsociated gene\u2019\u2013a new blood biomarker?","volume":"12","author":"Jellinger","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","article-title":"Blood-based biomarkers of microvascular pathology in Alzheimer\u2019s disease","volume":"45","author":"Ewers","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib10","first-page":"1","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ibneur.2025.01.004_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnmol.2017.00030","article-title":"Therapeutic potential of secreted amyloid precursor protein APPs\u03b1","volume":"10","author":"Mockett","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019430","article-title":"Presenilin\/\u03b3-secretase regulates neurexin processing at synapses","volume":"6","author":"Saura","year":"2011","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.004_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3233\/JAD-142721","article-title":"Evaluation of candidate genes related to neuronal apoptosis in late-onset Alzheimer's disease","volume":"45","author":"Moreno-Grau","year":"2015","journal-title":"J. Alzheimer'S. Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: targeting the cholinergic system","volume":"14","author":"H Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib16","article-title":"Alzheimer's disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimer'S. Dement.: Transl. Res. Clin. Interv."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.22670","article-title":"From the liver to the blood\u2013brain barrier: an interconnected system regulating brain amyloid-\u03b2 levels","volume":"89","author":"Sagare","year":"2011","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-190848","article-title":"Is Alzheimer\u2019s disease a liver disease of the brain?","volume":"75","author":"Bassendine","year":"2020","journal-title":"J. Alzheimer'S. Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of Alzheimer's disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann. Neurosci."},{"issue":"9","key":"10.1016\/j.ibneur.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-\u03b2 by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00401-023-02559-z","article-title":"Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease","volume":"145","author":"Cheng","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.ibneur.2025.01.004_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001358","article-title":"Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype","volume":"19","author":"Lam","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106570","article-title":"Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding","volume":"199","author":"Chandrashekar","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"6012","key":"10.1016\/j.ibneur.2025.01.004_bib24","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2014.00176","article-title":"Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-\u03b2 brain balance and the putative role of PPARs","volume":"6","author":"Zolezzi","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.24270","article-title":"Amyloid-\u03b2 efflux from the central nervous system into the plasma","volume":"76","author":"Roberts","year":"2014","journal-title":"Ann. Neurol."},{"issue":"44","key":"10.1016\/j.ibneur.2025.01.004_bib27","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer's Abeta40 and Abeta42","volume":"279","author":"Ghiso","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2018.07.020","article-title":"Characterization of dural sinus-associated lymphatic vasculature in human Alzheimer's dementia subjects","volume":"73","author":"Goodman","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ibneur.2025.01.004_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119329","article-title":"Imaging perivascular space structure and function using brain MRI","volume":"257","author":"Barisano","year":"2022","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00234-021-02718-7","article-title":"Perivascular spaces and brain waste clearance systems: relevance for neurodegenerative and cerebrovascular pathology","volume":"63","author":"Gouveia-Freitas","year":"2021","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.004_bib31","first-page":"584","article-title":"Contribution of direct cerebral vascular transport in brain substance clearance","volume":"15","author":"Wen","year":"2024","journal-title":"Aging Dis."},{"issue":"12","key":"10.1016\/j.ibneur.2025.01.004_bib32","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b2(1-42) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","article-title":"Low-density lipoprotein receptor-related protein 1: a physiological A\u03b2 homeostatic mechanism with multiple therapeutic opportunities","volume":"136","author":"Sagare","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"21","key":"10.1016\/j.ibneur.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1074\/jbc.M112.439570","article-title":"A lipoprotein receptor cluster IV mutant preferentially binds amyloid-\u03b2 and regulates its clearance from the mouse brain","volume":"288","author":"Sagare","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","article-title":"Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease","volume":"130","author":"Xiang","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.004_bib37","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid \u03b2-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.004_bib38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid \u03b2-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."},{"issue":"46","key":"10.1016\/j.ibneur.2025.01.004_bib39","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","article-title":"LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-\u03b2","volume":"32","author":"Kanekiyo","year":"2012","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib40","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.ibneur.2025.01.004_bib41","doi-asserted-by":"crossref","unstructured":"McLaurin J, Darabie A, Morrison M. Cholesterol, a modulator of membrane-associated a\u03b2-fibrillogenesis. Pharmacopsychiatry. 2003;36(S 2):130-135.","DOI":"10.1055\/s-2003-43054"},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1194\/jlr.M001859","article-title":"Enrichment of cholesterol in microdissected Alzheimer\u2019s disease senile plaques as assessed by mass spectrometry","volume":"51","author":"Panchal","year":"2010","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/clc.22361","article-title":"Cholesterol, statins, and dementia: what the cardiologist should know","volume":"38","author":"Wanamaker","year":"2015","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","article-title":"Cholesterol homeostasis failure as a unifying cause of synaptic degeneration","volume":"229","author":"Koudinov","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"18","key":"10.1016\/j.ibneur.2025.01.004_bib45","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1523\/JNEUROSCI.21-18-07226.2001","article-title":"A novel action of Alzheimer's amyloid \u03b2-protein (A\u03b2): oligomeric A\u03b2 promotes lipid release","volume":"21","author":"Michikawa","year":"2001","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.004_bib46","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","article-title":"Essential role for cholesterol in synaptic plasticity and neuronal degeneration","volume":"15","author":"Koudinov","year":"2001","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","article-title":"Non-alcoholic fatty liver disease induces signs of Alzheimer\u2019s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model","volume":"13","author":"Kim","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib48","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/jcbfm.2014.48","article-title":"Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus","volume":"34","author":"Calvo-Ochoa","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.ibneur.2025.01.004_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.654509","article-title":"Western diet induces impairment of liver-brain axis accelerating neuroinflammation and amyloid pathology in Alzheimer's disease","volume":"13","author":"Wi\u0229ckowska-Gacek","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jinorgbio.2009.09.026","article-title":"Accumulation of Eu3+\u2009chelates in cells expressing or not P-glycoprotein: implications for blood-brain barrier crossing","volume":"104","author":"Darghal","year":"2010","journal-title":"J. Inorg. Biochem"},{"key":"10.1016\/j.ibneur.2025.01.004_bib51","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s12035-020-02211-x","article-title":"The interplay of ABC transporters in A\u03b2 translocation and cholesterol metabolism: implicating their roles in Alzheimer\u2019s disease","volume":"58","author":"Behl","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphys.2013.00045","article-title":"The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease","volume":"4","author":"Elali","year":"2013","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.004_bib53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JAD-240212","article-title":"Approaches for increasing cerebral efflux of amyloid-\u03b2 in experimental systems","volume":"100","author":"Loeffler","year":"2024","journal-title":"J. Alzheimer'S. Dis.: JAD"},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/febs.15148","article-title":"P-glycoprotein: a role in the export of amyloid-\u03b2 in Alzheimer's disease?","volume":"287","author":"Chai","year":"2020","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010246","article-title":"New evidence for P-gp-mediated export of amyloid-\u03b2 peptides in molecular, blood-brain barrier and neuronal models","volume":"22","author":"Chai","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.004_bib56","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/1567205018666210906092940","article-title":"Effect of high cholesterol regulation of LRP1 and RAGE on A\u03b2 transport across the blood-brain barrier in Alzheimer\u2019s Disease","volume":"18","author":"Zhou","year":"2021","journal-title":"Curr. Alzheimer Res."},{"issue":"22","key":"10.1016\/j.ibneur.2025.01.004_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood-brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.ibneur.2025.01.004_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010964","article-title":"Pathology of amyloid-\u03b2 (A\u03b2) peptide peripheral clearance in Alzheimer's disease","volume":"25","author":"Tsoy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2025.01.004_bib59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ibneur.2024.07.002","article-title":"Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer's patients: A double-blind placebo-controlled randomized clinical trial","volume":"17","author":"Rustamzadeh","year":"2024","journal-title":"IBRO Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.004_bib60","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ana.20289","article-title":"Serum lipids and hippocampal volume: the link to Alzheimer's disease?","volume":"56","author":"Wolf","year":"2004","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/bbrc.2000.2372","article-title":"High density lipoprotein inhibits assembly of amyloid \u03b2-peptides into fibrils","volume":"270","author":"Olesen","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00001756-200203250-00019","article-title":"Diet-induced hypercholesterolemia enhances brain A\u03b2 accumulation in transgenic mice","volume":"13","author":"Shie","year":"2002","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bst0300525","article-title":"Cholesterol and Alzheimer's disease","volume":"30","author":"Wolozin","year":"2002","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.004_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/JAD-2008-14202","article-title":"Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat","volume":"14","author":"Granholm","year":"2008","journal-title":"J. Alzheimer'S. Dis."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.mcn.2010.08.001","article-title":"Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits","volume":"45","author":"Ullrich","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ibneur.2025.01.004_bib67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","article-title":"Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: potential novel targets for treatment","volume":"190","author":"Loera-Valencia","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.004_bib68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000520514","article-title":"Metabolism and the effect of animal-derived oxysterols in the diet on the development of Alzheimer\u2019s disease","volume":"78","author":"Choroszy\u0144ski","year":"2022","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.ibneur.2025.01.004_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105426","article-title":"Localisation of oxysterols at the sub-cellular level and in biological fluids","volume":"193","author":"Dias","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fnagi.2015.00119","article-title":"Oxidized cholesterol as the driving force behind the development of Alzheimer\u2019s disease","volume":"7","author":"Gamba","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2025.01.004_bib71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fnins.2019.00556","article-title":"A crosstalk between brain cholesterol oxidation and glucose metabolism in Alzheimer\u2019s disease","volume":"13","author":"Gamba","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib72","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/cercor\/bhy274","article-title":"27-Hydroxycholesterol induces aberrant morphology and synaptic dysfunction in hippocampal neurons","volume":"29","author":"Merino-Serrais","year":"2019","journal-title":"Cereb. cortex"},{"issue":"9","key":"10.1016\/j.ibneur.2025.01.004_bib74","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","article-title":"Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease","volume":"11","author":"Papassotiropoulos","year":"2000","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib75","article-title":"Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17\u03b2","volume":"108","author":"K\u00f6sch","year":"2001","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2010.03.078","article-title":"Effects of cholesterol oxidation products on exocytosis","volume":"476","author":"Ma","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2025.01.004_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105785","article-title":"Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer\u2019s cerebral pathology and clinical disease progression","volume":"205","author":"Jahn","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib78","first-page":"1235","article-title":"High\u2011cholesterol diet results in elevated amyloid\u2011\u03b2 and oxysterols in rats","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib79","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archneur.60.4.510","article-title":"Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease","volume":"60","author":"Vega","year":"2003","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.004_bib80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamaneurol.2019.0648","article-title":"Association of early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB","volume":"76","author":"Wingo","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/184042","article-title":"Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease","volume":"2012","author":"Bowman","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib82","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","article-title":"Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease","volume":"111","author":"Martins","year":"2009","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer\u2019s disease\u2729","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2025.01.004_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2014.07.007","article-title":"Oxidized low density lipoprotein increases acetylcholinesterase activity correlating with reactive oxygen species production","volume":"78","author":"Yamchuen","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ibneur.2025.01.004_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146554","article-title":"Elevated serum TC and LDL-C levels in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis study","volume":"1727","author":"Liu","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2025.01.004_bib86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2014.03.017","article-title":"Increased 27-hydroxycholesterol plasma level in men with low high density lipoprotein-cholesterol may circumvent their reduced cell cholesterol efflux rate","volume":"433","author":"Nunes","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ibneur.2025.01.004_bib87","article-title":"High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population","volume":"22","author":"Kinno","year":"2019","journal-title":"NeuroImage: Clin."},{"issue":"12","key":"10.1016\/j.ibneur.2025.01.004_bib88","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1021\/bi002186k","article-title":"Apolipoprotein AI directly interacts with amyloid precursor protein and inhibits A\u03b2 aggregation and toxicity","volume":"40","author":"Koldamova","year":"2001","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.004_bib89","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/molecules25102439","article-title":"The positive side of the Alzheimer\u2019s disease amyloid cross-interactions: the case of the A\u03b2 1-42 peptide with tau, TTR, CysC, and ApoA1","volume":"25","author":"Ciccone","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.004_bib90","doi-asserted-by":"crossref","first-page":"a011452","DOI":"10.1101\/cshperspect.a011452","article-title":"Neurovascular dysfunction and faulty amyloid \u03b2-peptide clearance in Alzheimer disease","volume":"2","author":"Sagare","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.004_bib91","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-151068","article-title":"Apolipoprotein A1 in cerebrospinal fluid and plasma and progression to Alzheimer\u2019s disease in non-demented elderly","volume":"56","author":"Slot","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.ibneur.2025.01.004_bib92","unstructured":"McNeill E. RVX-208, a stimulator of apolipoprotein AI gene expression for the treatment of cardiovascular diseases. Current opinion in investigational drugs (London, England: 2000). 2010;11(3):357-364."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nano.2015.09.003","article-title":"The hunt for brain A\u03b2 oligomers by peripherally circulating multi-functional nanoparticles: potential therapeutic approach for Alzheimer disease","volume":"12","author":"Mancini","year":"2016","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.ibneur.2025.01.004_bib94","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29595","article-title":"Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels","volume":"6","author":"Robert","year":"2017","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib95","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2014.01.003","article-title":"High-density lipoproteins and cerebrovascular integrity in Alzheimer\u2019s disease","volume":"19","author":"Stukas","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ibneur.2025.01.004_bib96","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2021.08.018","article-title":"High-density lipoprotein in Alzheimer's disease: from potential biomarkers to therapeutics","volume":"338","author":"Jin","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ibneur.2025.01.004_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120272","article-title":"Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures","volume":"596","author":"Gupta","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.004_bib98","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-140111","article-title":"Apolipoprotein C-III is an amyloid-\u03b2-binding protein and an early marker for Alzheimer's disease","volume":"41","author":"Shih","year":"2014","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.ibneur.2025.01.004_bib99","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fnagi.2020.00223","article-title":"Blood-based biomarkers for predictive diagnosis of cognitive impairment in a Pakistani population","volume":"12","author":"Iqbal","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"20","key":"10.1016\/j.ibneur.2025.01.004_bib100","doi-asserted-by":"crossref","first-page":"e2088","DOI":"10.1212\/WNL.0000000000009436","article-title":"Serum triglycerides in Alzheimer disease: relation to neuroimaging and CSF biomarkers","volume":"94","author":"Bernath","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ibneur.2025.01.004_bib101","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jagp.2016.03.001","article-title":"Association between serum triglycerides and cerebral amyloidosis in cognitively normal elderly","volume":"24","author":"Choi","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nbd.2006.06.007","article-title":"Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer\u2019s disease mouse models with abundant A\u03b2 in plasma","volume":"24","author":"Burgess","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib103","doi-asserted-by":"crossref","first-page":"E1736","DOI":"10.1152\/ajpendo.00122.2007","article-title":"PPAR\u03b3 regulates adipose triglyceride lipase in adipocytes in vitro and in vivo","volume":"293","author":"Kershaw","year":"2007","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"issue":"30","key":"10.1016\/j.ibneur.2025.01.004_bib104","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","article-title":"Mechanisms underlying the rapid peroxisome proliferator-activated receptor-\u03b3-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease","volume":"32","author":"Mandrekar-Colucci","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2025.01.004_bib105","first-page":"510","article-title":"Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition","volume":"11","author":"Risacher","year":"2019","journal-title":"Alzheimer'S. Dement.: Diagn., Assess. Dis. Monit."},{"key":"10.1016\/j.ibneur.2025.01.004_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0549-1","article-title":"Plasma A\u03b242\/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study","volume":"11","author":"P\u00e9rez-Grijalba","year":"2019","journal-title":"Alzheimer'S. Res. Ther."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib107","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-210496","article-title":"Predictive accuracy of blood-derived biomarkers for amyloid-\u03b2 brain deposition along with the Alzheimer\u2019s disease continuum: a systematic review","volume":"84","author":"Cianflone","year":"2021","journal-title":"J. Alzheimer'S. Dis."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.004_bib108","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/ggi.12147","article-title":"Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease","volume":"14","author":"Yamamoto","year":"2014","journal-title":"Geriatr. Gerontol. Int."},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.004_bib109","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1212\/WNL.0b013e3181b78448","article-title":"Association of plasma amyloid \u03b2 with risk of dementia: the prospective three-city study","volume":"73","author":"Lambert","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.004_bib110","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awaa054","article-title":"Plasma tau, neurofilament light chain and amyloid-\u03b2 levels and risk of dementia; a population-based cohort study","volume":"143","author":"de Wolf","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2025.01.004_bib111","first-page":"1","article-title":"Effects of simvastatin on plasma amyloid-\u03b2 transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial","author":"Wei","year":"2022","journal-title":"J. Alzheimer'S. Dis."},{"issue":"12","key":"10.1016\/j.ibneur.2025.01.004_bib112","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.ibneur.2025.01.004_bib113","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02086-2","article-title":"Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis","volume":"18","author":"Lai","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ibneur.2025.01.004_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120011","article-title":"Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: a first step of a potential strategy for the treatment of Alzheimer\u2019s disease","volume":"591","author":"Arduino","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"22","key":"10.1016\/j.ibneur.2025.01.004_bib116","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00170-19","article-title":"MicroRNA 7 impairs insulin signaling and regulates A\u03b2 levels through posttranscriptional regulation of the insulin receptor substrate 2, insulin receptor, insulin-degrading enzyme, and liver X receptor pathway","volume":"39","author":"Fern\u00e1ndez-de Frutos","year":"2019","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib117","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/jnc.15716","article-title":"Poly(I:C) promotes neurotoxic amyloid \u03b2 accumulation through reduced degradation by decreasing neprilysin protein levels in astrocytes","volume":"163","author":"Yamamoto","year":"2022","journal-title":"J. Neurochem"},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.004_bib118","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbapap.2011.02.011","article-title":"Binding studies of truncated variants of the A\u03b2 peptide to the V-domain of the RAGE receptor reveal A\u03b2 residues responsible for binding","volume":"1814","author":"Gospodarska","year":"2011","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.ibneur.2025.01.004_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2315106","article-title":"Metformin ameliorates A\u03b2 pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer\u2019s disease","volume":"2020","author":"Lu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ibneur.2025.01.004_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-1191-4","article-title":"The relationship between blood lipids and plasma amyloid beta is depend on blood pressure: a population-based cross-sectional study","volume":"19","author":"Hu","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.004_bib121","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mad.2008.09.002","article-title":"Regulation of \u03b2-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer\u2019s disease","volume":"129","author":"Prasanthi","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ibneur.2025.01.004_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.650679","article-title":"Blood pressure level is associated with changes in plasma A\u03b21\u201340 and A\u03b21\u201342 levels: a cross-sectional study conducted in the suburbs of Xi\u2019an, China","volume":"13","author":"She","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.004_bib123","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.119.230458","article-title":"Correlation of Alzheimer disease neuropathologic staging with amyloid and tau scintigraphic imaging biomarkers","volume":"61","author":"Koychev","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"25","key":"10.1016\/j.ibneur.2025.01.004_bib124","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.ibneur.2025.01.004_bib125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain\u2014implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2025.01.004_bib126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fnagi.2016.00223","article-title":"In vivo differential brain clearance and catabolism of monomeric and oligomeric Alzheimer's A\u03b2 protein","volume":"8","author":"McIntee","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.004_bib127","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"13","key":"10.1016\/j.ibneur.2025.01.004_bib128","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/j.1460-2075.1988.tb03306.x","article-title":"Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor","volume":"7","author":"Herz","year":"1988","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.004_bib129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00353892","article-title":"Distribution of the \u03b12-macroglobulin receptor\/low density lipoprotein receptor-related protein in human tissues","volume":"269","author":"Moestrup","year":"1992","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.004_bib130","first-page":"605","article-title":"Clearance of Alzheimer's Abeta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.004_bib131","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13258","article-title":"Alzheimer\u2019s amyloid \u03b2 heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis","volume":"19","author":"Parodi-Rull\u00e1n","year":"2020","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib132","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2010-101248","article-title":"Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-\u03b2 is an early biomarker for mild cognitive impairment preceding Alzheimer's disease","volume":"24","author":"Sagare","year":"2011","journal-title":"J. Alzheimer'S. Dis."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.004_bib133","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1194\/jlr.R075796","article-title":"Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies: thematic review series: ApoE and Lipid Homeostasis in Alzheimer's Disease","volume":"58","author":"Shinohara","year":"2017","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib134","first-page":"827","article-title":"Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid \u03b2\u2011related transporters RAGE and LRP\u20111 in a rat model of Alzheimer's disease","volume":"17","author":"Hu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-40736-x","article-title":"Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus","volume":"9","author":"Seok","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.01.004_bib136","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2017.05.011","article-title":"Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier","volume":"57","author":"Osgood","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib137","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0169-328X(02)00203-6","article-title":"LRP and senile plaques in Alzheimer\u2019s disease: colocalization with apolipoprotein E and with activated astrocytes","volume":"104","author":"Ar\u00e9lin","year":"2002","journal-title":"Mol. brain Res."},{"issue":"21","key":"10.1016\/j.ibneur.2025.01.004_bib138","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1074\/jbc.M101589200","article-title":"Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates","volume":"276","author":"Li","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.ibneur.2025.01.004_bib139","doi-asserted-by":"crossref","first-page":"18521","DOI":"10.1016\/S0021-9258(17)32340-2","article-title":"Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons","volume":"269","author":"Bu","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.ibneur.2025.01.004_bib140","doi-asserted-by":"crossref","first-page":"34554","DOI":"10.1074\/jbc.M801487200","article-title":"The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid \u03b2 peptides in an in vitro model of the blood-brain barrier cells","volume":"283","author":"Yamada","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2025.01.004_bib141","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.ibneur.2025.01.004_bib142","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid \u03b2-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor\u2013related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.004_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011884","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal A\u03b242 uptake and lysosomal trafficking","volume":"5","author":"Fuentealba","year":"2010","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.004_bib144","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.004_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/fn.2013.34190","article-title":"Molecular mechanisms of neuropathological changes in Alzheimer\u2019s disease: a review","volume":"51","author":"\u0160er\u00fd","year":"2013","journal-title":"Folia Neuropathol."},{"issue":"7","key":"10.1016\/j.ibneur.2025.01.004_bib146","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:35:03Z","timestamp":1784360103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242125000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":146,"alternative-id":["S2667242125000053"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.01.004","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}